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Abstract
Aim: A splenectomy and splenic artery ligation accelerate liver regeneration and improve liver function
after a hepatectomy. However, there are no studies that directly compared the effects of a splenectomy
and splenic artery ligation. In the present study, we compared the effects of a splenectomy and splenic
artery ligation in cirrhotic rats.hpb_116 22..30
Methods: Dimethylnitrosamine (DMN) was administered intraperitoneally for 4 weeks to induce cirrho-
sis. The rats were divided into three groups: sham operation (CT group), splenic artery ligation (SAL group)
and splenectomy (SP group). Liver functions [alanine aminotransferase (ALT) and total bilirubin (T. Bil)],
plasma TGF-b1, histopathological changes, extent of liver fibrosis (fibrotic rate) and regeneration [Ki-67
labelling index(LI)] were investigated in each group.
Results: ALT and T. Bil levels were significantly lower in the SP group than the CT and SAL groups.
TGF-b1 levels were significantly lower in the SP group than in the CT and SAL groups. The fibrotic rate
was significantly lower in the SP group than in the CT and SAL groups. The Ki-67 labelling index was
significantly higher in the SP group than in the CT and SAL groups.
Discussion: A Splenectomy significantly improved liver regeneration with reduction of plasma TGF-b1
levels compared with splenic artery ligation in DMN-treated cirrhotic rats.
Keywords
liver cirrhosis, liver regeneration, spleen, splenectomy, splenic arterial ligation, TGF-b1
Received 20 December 2009; accepted 13 July 2009
Correspondence
Akio Morinaga, Department of Surgery, Kurume University School of Medicine, 67 Asahi-machi,
Kurume-city, Fukuoka 830-0011, Japan. Tel: 81 942 35 3311; Fax: 81 942 35 8967; E-mail:
morinaga-akio@kurume-u.ac.jp
Introduction
Functional deterioration of the liver is a common problem in
patients with cirrhosis associated with hepatocellular carcinoma
(HCC) especially those with a background of viral hepatitis B or
C. Liver regeneration in patients with cirrhosis is a promising way
to improve the functional status of the liver. Experimental studies
have reported that splenomegaly inhibits liver regeneration in
liver cirrhosis.1,2 After a partial hepatectomy in cirrhotic patients
with splenomegaly, the remnant liver tends to regenerate to a
smaller volume than in patients free of splenomegaly,3 and sple-
nectomy improves the post-operative function of the hepatecto-
mized cirrhotic liver.4–6 Experiments in cirrhotic rats have
demonstrated better hepatic regeneration in splenectomized rats
than the sham-operated counterparts.1,7
Previous reports also described improvement of liver function
after splenic artery ligation with splenic preservation. In HCC
patients with liver cirrhosis, splenic artery ligation reduced the
incidence of post-operative hepatopathy.8 In small-for-size grafts
for living-donor adult liver transplantation, graft survival
improved after the adoption of the splenic artery ligation
technique.9,10 Previous studies have showed that a splenectomy
accelerates liver regeneration compared with sham-operated
cirrhotic rats. On the other hand, splenic artery ligation in
either liver transplantation or hepatectomy has also been
reported to significantly improve post-operative liver function.
Although there are no reports indicating improvement of liver
regeneration after splenic artery ligation, it is nevertheless
presumed that splenic artery ligation could improve liver
regeneration.
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To our knowledge, there are no reports that directly compared
the effects of splenectomy and splenic artery ligation on the liver
function and regeneration in patients with cirrhosis. The present
experimental study was designed to address this issue using a
cirrhotic rat model.
Materials and methods
Animals
Sixty-four male Wister rats weighing 250–350 g (Kyudo; Kuma-
moto, Japan) were used in all experiments. They were housed in
wire-topped metal cages in a temperature-controlled room (21
2°C) and constant light-dark cycle (12 h light, 12 h dark). All rats
received food and water ad libitum throughout the study and the
bedding in the cages was changed once a week. The animals were
fasted for 12 h before the operation. All rats were anaesthetized
with intraperitoneal injection of Nembutal at 50 mg/kg body
weight (Tokyo, Japan). All experiments were conducted in accor-
dance with the National Institute of Health Guidelines for the
Care and Use of Laboratory Animals and were approved by
the Institutional Animal Care and Use Committee of Kurume
University.
Study design
Eight rats were used as controls and sacrificed for the collection of
tissues and portal blood [before injection of dimethylnitrosamine
(DMN) (Wako, Osaka, Japan)]. The other 56 rats were treated
with DMN to induce persistent liver fibrosis, which closely
resembles human cirrhosis, as confirmed in previous studies.11,12
DMN (1% dissolved in saline) was injected intraperitoneally at a
dose of 1 ml/kg body weight, three times a week (on 3 consecutive
days with 4 days off per week) for 4 weeks. After the last DMN
injection, eight rats were sacrificed for the collection of tissue and
portal blood specimens (before operation, n = 8). Ten days after
the last DMN injection, surgical exploration of the remaining rats
showed granular liver surface, massive splenomegaly, ascites and
collateral venous circulation around the spleen. The remaining 48
rats were randomly divided in three groups: the sham operation
group (CT group, n = 16), the splenic artery ligation group (SAL
group, n = 16) and the splenectomy group (SP group, n = 16). Out
of the 48 rats, 24 (8 of each group) were sacrificed during the
operation for the collection of specimens. The remaining 24 rats
(8 for each group) were sacrificed 30 days after the operation (30
POD). All rats were sacrificed by an overdose of anaesthetic agent.
At sacrifice, portal blood was collected for liver function tests and
measurement of transforming growth factor-b1 (TGF-b1). The
whole liver lobes and body were weighed at the indicated time
points. The liver and the spleen were excised for histopathology
and immunohistochemistry. Each organ was divided into thin
slices and fixed with phosphate-buffered 10% neutral formalin.
The fixed sections were used to estimate liver fibrosis and
regeneration.
Operative procedures
For splenectomy, the abdomen was opened through a midline
incision. The spleen was mobilized to the centre of the operative
field after dissecting the surrounding ligaments. The hilar vessels
were ligated with 3-0 silk suture. The spleen was removed and the
abdominal incision was closed. For splenic artery ligation, the
abdomen was opened and the splenic artery was dissected and
carefully isolated from the splenic vein. Then it was ligated about
1.5 cm proximal to the bifurcation of the hilar vessels, at two
adjacent locations, with 4-0 silk and the abdomen was closed. The
sham operation was performed exactly as for the splenectomy
and splenic artery ligation, but the last two procedures were not
performed.
Liver function tests and measurement of TGF-b1
The blood samples collected from the portal vein were immedi-
ately centrifuged at 2000¥ g for 10 min at 4°C and stored at –80°C
until use for liver function tests. Serum alanine aminotransferase
(ALT) and total bilirubin (T. Bil) levels were estimated. The ratios
of ALT and T. Bil to liver weight at a given time point were
calculated. Data reported for each time point represent the mean
 SD of eight animals.
Plasma TGF-b1 was assayed using the Quantikine human
TGF-b1 enzyme-linked immunosorbent assay (ELISA) kit (R & D
Systems, Minneapolis, MN, USA) according to the manufacturer’s
protocol. Briefly, sandwich ELISA was set in a 96-well microtitre
plate to estimate TGF-b1 levels and a monoclonal antibody was
used for the first antibody analysis. The colour intensity was
analysed quantitatively by measuring absorbance at 450 nm with
a micro-plate reader E-max (Molecular Devices, Sunnyvale, CA,
USA). The concentration in the test sample was determined based
on a standard curve prepared with samples of known concentra-
tions. The ratio of TGF-b1 to liver weight at a given time point to
liver weight was calculated. Data reported for each time point
represent the mean  SD of eight animals.
Assessment of histopathological changes
The liver specimens were fixed in phosphate-buffered 10% neutral
formalin solution, embedded in paraffin, and then were serially
cut into thin slices and placed on glass slides. After deparaffiniza-
tion, the sections were stained with hematoxylin and eosin for
histopathological examination. The specimens were examined by
a pathologist who was blinded to the animal groups and tissue
sampling. Histopathological assessment was performed based on
the degeneration of hepatocytes, hepatic necrosis and infiltration
of inflammatory cells such as neutrophils, lymphocytes and mac-
rophages. Histopathological changes were graded as follow: mild
(slight inflammatory cells infiltration in the tissue), moderate
(moderate degeneration of hepatocytes and /or moderate inflam-
matory cell infiltration) and severe (focal necrosis and /or severe
degeneration of hepatocytes with inflammatory cell infiltration).
The adjacent category model was applied to the categorical data.
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Assessment of liver fibrosis
The formalin-fixed liver tissue was embedded in paraffin and cut
into 4-mm thick sections. Sections were stained with Azan-
Mallory stain to estimate the degree of liver fibrosis. The degree of
fibrosis was morphometrically defined as the ratio of randomly
selected connective tissue to the whole area of the liver (10 fields
selected at random from each of 3 rats; a total of 30 fields for each
group were examined), using an image analysis technique (NIH
image software package) (Scion Corporation, Frederick, MD,
USA).13 Values are presented as mean  SD.
Assessment of liver regeneration
Changes in body weight were measured in all groups before DMN
injection, before the operation, during the operation and 30 days
after the operation. After euthanasia, the liver was dissected out
and weighed. The ratio of liver weight at a given time point to
body weight was calculated. The liver regeneration rate (%) was
calculated using the following equation. Liver regeneration rate
(%) = 100 ¥ liver weight (LW)/body weight (BW) at a given time
point. Each point represents the mean  SD of eight animals.
Using immunohistochemistry, Ki-67-stain was to evaluate liver
regeneration after the operation. The liver sections were deparaf-
finized with xylene and immersed in absolute and 95% ethanol for
15 s each. After washing in phosphate-buffered saline (PBS), the
sections were incubated in 3% hydrogen peroxide solution for
inactivation of endogenous tissue peroxidase, and subsequently in
5% skimmed milk for blocking non-specific immunoreactions.
The sections were then autoclaved in citrate buffer (pH 6.0) at
95°C for 35 min. The sections were again incubated with anti-
rat secondary antibody (LSAB2 kit; Dako, Tokyo, Japan) diluted
1 : 50 with PBS at room temperature for 30 min. After washing
in PBS, the sections were incubated with a streptavidin-biotin
staining kit (Histofine SAB-PO kit, Nichirei, Tokyo) at room
temperature for 30 min. Immunocomplexes were visualized by
3.3′-diaminobenzidine tetrahydrochloride (Dako) and then the
sections were counterstained with hematoxylin. The Ki-67 label-
ling index (LI) represented the percentage of Ki-67-stained hepa-
tocytes per total number of hepatocytes in randomly chosen
sections (under 100¥magnification, 10 fields selected at random
from each of 3 rats; a total of 30 fields were examined in each
group).14
Statistical analysis
All values were expressed as the mean standard devia-
tion (SD). Differences between groups were examined for
statistical significance using the Student’s t-test. Polytomous
logistic regression was performed to compare histological
changes. A P-value less than 0.05 was considered statistically
significant.
Results
Effects of a splenectomy and splenic artery ligation
on serum ALT and T. Bil levels
The mean serum ALT level at 30 POD was significantly lower in
the SP group (7.2  1.3 umol/10 dl/g), but not the SAL group
(17.2  1.8), than in the CT group (20.1  2.1, P < 0.01).
Although the level in the SAL group tended to be lower than in the
CT group, the difference was not significant (P = 0.240). Serum
T. Bil levels in the SP (3.5  2.1 umol/dl/g) and SAL groups
(6.7  3.7) were significantly lower than that of the CT group
(16.4  4.1) (P < 0.05, each) (Fig. 1).
Effects of a splenectomy and splenic artery ligation
on plasma TGF-b1 concentration in the portal vein
The mean plasma TGF-b1 level in the portal vein at 30 POD was
significantly lower in the SP group (2.1  1.9 umol/dl/g) than in
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Figure 1 Serum levels of alanine aminotransferase (ALT) (left), total bilirubin (T. Bil) (right). Sham operation (CT) group (), splenic artery
ligation (SAL) group (), splenectomy (SP) group () at 30 days after the operation (POD). Data are mean  SD of eight rats. Statistical
analysis was performed using Student's t-test.
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the CT group (8.2  2.6) and SAL group (7.2  1.8) (P < 0.01,
each) (Fig. 2). Although the level in the SAL group tended to be
lower than in the CT group, the difference was not significant
(P = 0.282).
Effects of a splenectomy and splenic artery ligation
on histopathology of the liver
At 30 POD, the liver tissue of the CT group showed centrizonal
necrosis and severe degeneration of hepatocytes with marked
inflammatory cell infiltration (Fig. 3a). On the other hand, mod-
erate inflammatory cell infiltration and degeneration of hepa-
tocytes were found in the SAL group (Fig. 3b). In contrast, the
SP group showed only slight inflammatory cell infiltrations
(Fig. 3c).
Table 1 summarizes the histopathological findings at 30 days
POD. These findings were significantly different between the CT
and SP groups (P < 0.001), and also between the SP and SAL
groups (P < 0.05), but marginally different between the CT and
SAL groups (P = 0.075).
Effects of splenic artery ligation on histopathology of
the spleen
Gross examinations showed severe atrophic changes in the SAL
group at 30 POD. Microscopy revealed slight passive congestion
in the red pulp (Fig. 4a). None of the sections of the SAL group
showed infarction or necrosis (Fig. 4a). On the other hand,
no congestion was observed in the spleen of normal rats
(Fig. 4b).
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Figure 2 Plasma concentrations of TGF-b1 in the portal vein. Sham
operation (CT) group (), splenic artery ligation (SAL) group (),
splenectomy (SP) group () at 30 days after the operation (POD).
Data are mean SD of eight rats. Statistical analysis was performed
using Student's t-test.
Figure 3 Histopathology of the liver at 30 days after the operation in the three groups (hematoxylin-eosin staining, original magnifica-
tion¥100). In the sham operation (CT) group, centrizonal necrosis was associated with severe inflammatory cell infiltration, consisting of
neutrophils, lymphocytes and haemosiderin-laden macrophages. Degenerative hepatocytes in zone 2 showed marked hydropic swelling (a).
In the splenic artery ligation (SAL) group, focal necrosis and degenerative hepatocytes were found in zone 3 with moderate degree of
inflammatory cell infiltration (b). In the splenectomy (SP) group, the hepatic cord was straight and the parenchyma showed only mild
inflammatory cell infiltration but no focal necrosis (c).
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Effects of a splenectomy and splenic artery ligation
on liver fibrosis
Azan-Mallory staining of the liver before the operation and at 30
POD showed severe fibrosis and inflammatory cell infiltration
within the fibrous septa in the CT group (Fig. 5a–b). On the other
hand, liver fibrosis was less extensive in the SAL group than in the
CT group (Fig. 5c). Although bridging fibrosis was seen in the SP
group, it was markedly less compared with the SAL group
(Fig. 5d).The mean fibrotic rate of the liver before the operation
and at 30 POD in the CT, SAL and SP groups were 10.7  3.2%,
10.5 3.7%, 8.6 2.1%, and 3.1 2.2%, respectively. The mean
fibrotic rate of the liver was not significantly different between
before the operation and CT group at 30 POD (P = 0.524), but was
significantly lower between the SP group and CT and SAL groups
(SP vs. CT P < 0.001, SP vs. SAL P < 0.01). The mean fibrotic rate
was significantly lower in the SAL group than in the CT groups
(P < 0.01) (Fig. 6).
Effects of a splenectomy and splenic artery ligation
on liver regeneration and Ki-67 LI
The mean liver regeneration rates before DMN injection, before
the operation and 30 POD in the CT, SAL and SP groups were 1.4
 0.1%, 2.7  0.1%, 2.6  0.1%, 2.7  0.2% and 4.6  0.2%,
respectively. The liver regeneration rate was significantly higher in
the SP group than in the CT and SAL groups at 30 POD (SP vs. CT
P < 0.01, SP vs. SAL P < 0.01), but not between the CT and SAL
groups at 30 POD (P = 0.523) (Fig. 7).
Ki-67 positive hepatocytes were rarely seen before the operation
(data not shown)in the CT and SAL groups (Fig. 8a–b). Immu-
nohistochemistry revealed enhanced liver regeneration in the 30
POD SP group as evidenced by the large number of Ki-67-positive
hepatocytes (Fig. 8c). The mean Ki-67 LI before the operation and
30 POD in the CT, SAL and SP groups were 6.1  2.3%, 6.3 
2.5%, 5.1  1.6% and 10.9  4.1%, respectively.
The Ki-67 LI was not significantly different between before the
operation and 30 POD in the CT group, but was significantly
higher between the SP group and CT and SAL groups (SP vs. CT-
P < 0.01, SP vs. SAL- P < 0.01). The Ki-67 LI was not significantly
different between the SAL and CT groups (P = 0.265) (Fig. 9).
Discussion
Cirrhosis can be experimentally induced in animal models by the
administration of CCl4 and thioacetamide (TAA). However, the
reported reproducibility of CCl4-induced cirrhosis is low and
associated with high mortality.13 Furthermore, induction of cir-
rhosis by TAA injections requires repeated injections over a long
period of time and the outcome is associated with hypersplenism.1
In our study, injection of rats with 1% DMN over a 4-week period
resulted in chronic liver fibrosis with pathological changes closely
resembling those of human liver cirrhosis.11,12 No significant
improvement of fibrosis was observed in the sham-operated rats
at 40 days after completion of DMN administration, indicating
that the cirrhotic changes in this model are irreversible even after
cessation of DMN injections.
Table 1 Histopathological findings at 30 days after the operation
Histopathological damage
Mild Moderate Severe
CT group – 2/8 6/8
SAL group 2/8 4/8 2/8
SP group 7/8 1/8 –
The sham operation (CT) group and the splenectomy (SP) group are
significantly different (Exact: P = 0.00011, Asymptotic: P = 0.003), the CT
group and the splenic artery ligation (SAL) group tended to be different
(Exact: P = 0.053, Asymptotic: P = 0.075), and the SP group and the SAL
group were significantly different (Exact: P = 0.036, Asymptotic: P =
0.029). Histopathological changes were graded as follow: mild (slight
inflammatory cell infiltration), moderate (moderate degeneration of hepa-
tocytes and /or moderate inflammatory cell infiltration) and severe (focal
necrosis and /or severe degeneration of hepatocytes with inflammatory
cell infiltration). The adjacent category model was applied to the cat-
egorical data (n = 8).
Figure 4 Histopathology of the spleen after splenic artery ligation (hematoxylin-eosin staining, original magnification ¥40). At 30 days after
the operation, rats of the splenic artery ligation (SAL) group showed mild congestion in the red pulp (a) compared with before dimethylni-
trosamine (DMN) injection (b). No splenic infarction or necrosis was observed in the SAL group (a).
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Several experimental studies have shown that the spleen plays
an inhibitory role in hepatic liver regeneration.1,2 There is evi-
dence that humoral factors produced by the splenic tissue are
carried to the liver through the portal circulation where they
inhibit liver regeneration.15,16 For example, spleen-derived TGF-b1
has been reported to play a central role in inhibiting the growth of
hepatocytes in animals.1,17,18 TGF-b1 is reported to inhibit liver
regeneration by facilitating tissue fibrosis in the liver.14,19 It also
acts directly on hepatocytes by inhibiting cell proliferation and
inducing apoptosis.20,21 Any injury to the liver induces transfor-
mation of hepatic stellate cells (HSC) to myofibroblast-like cells
(activated HSC), which produce extracellular matrix (ECM) pro-
teins.14 In this process, the production and accumulation of ECM
proteins are regulated by TGF-b1.19,22 Higher concentrations of
TGF-b1 induces ECM production with resultant liver fibrosis,
whereas suppression of TGF-b1 induces ECM degradation which
Figure 5 Histopathology of the liver after a splenectomy and splenic artery ligation (Azan-Mallory staining, original magnification ¥40). Severe
fibrosis was noted in rats before the operation (a) and at 30 days after the operation in the sham operation (CT) group (b), with no significant
difference between the two groups. The fibrosis was less extensive in the splenic artery ligation (SAL) group compared with the CT group
at 30 days after the operation (c). Although bridging fibrosis was noted in the splenectomy (SP) group, the fibrosis was markedly lower than
in the SAL group (d). Ten fields selected at random from each of three rats; a total of 30 fields were examined in each group.
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Figure 6 Assessment of liver fibrosis at 30 days after the operation
(POD). The severity of fibrosis was defined morphometrically as the
ratio of connective tissue to the whole area of the liver (Ten fields
selected at random from each of 3 rats; a total of 30 fields were
examined in each group), using image analysis techniques. Values
are mean  SD. For abbreviations, see Fig. 1.
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Figure 7 Assessment of liver regeneration at day 30 after the opera-
tion (POD). Bars represent mean  SD data of eight animals per
group. Statistical analysis using Student's t-test.
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further results in decreased liver fibrosis and improved liver regen-
eration.14,23 The level of spleen-derived TGF-b1 is considered a
determinant factor of ECM production or degradation.1 On the
other hand, activated HSC themselves produce TGF-b1, which
exerts an autocrine effect on hepatocytes inducing growth
inhibition.24–26
In the present study, histopathological examination of the liver
in the splenectomy group showed slight hepatic fibrosis with a
significant decrease in plasma TGF-b1 and a significant increase in
the Ki-67 LI, compared with the sham operation group. These
results support the previously described notion that splenic
TGF-b1 plays an important role in the facilitation of liver fibrosis
as well as inhibiting the regeneration of the damaged liver. Aka-
hoshi et al. postulated that the humoral factor, which originates
from the spleen of cirrhotic rat, is TGF-b1 and it is released into
the portal circulation.1 Ueda et al.18 showed strong TGF-b1
expression in the macrophages of the spleen in a liver-injury rat
model, and concluded that TGF-b1 was produced and secreted by
the spleen and removal of the spleen enhanced proliferation of
hepatocytes. To the best of our knowledge, this is the first report
describing changes in the TGF-b1 level in the portal vein after
splenic artery ligation in the cirrhotic rat model. Indeed, there are
no reports that directly compared the effects of splenectomy and
splenic artery ligation on liver regeneration in a rat model of liver
cirrhosis.
Our study showed significantly low plasma TGF-b1 levels in the
portal vein at 30 days after the splenectomy than in the splenic
artery ligation group. While a large number of Ki-67-positive
hepatocytes were observed after the splenectomy, they were
seldom seen after splenic artery ligation at 30 POD. These results
suggest that splenic artery ligation neither reduces plasma TGF-b1
levels nor influences liver regeneration. Indeed, the histopathol-
ogy of the spleen at 30 days after splenic artery ligation showed
only mild congestion, and infarction or necrosis were not
observed. Previous studies also reported the presence of
Figure 8 Immunohistochemical analysis of hepatocyte proliferation in dimethylnitrosamine (DMN)-treated cirrhotic rat liver (original magni-
fication ¥200). Note the more abundant Ki-67-positive hepatocytes in the splenectomy (SP) group (c) than the splenic artery ligation (SAL)
group (b) and the sham operation (CT) group (a). Ten fields selected at random from each of three rats; total of 30 fields were examined in
each group.
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SAL 30 POD
SP 30 POD
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#
*
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*P < 0.01; SP versus CT
Figure 9 Effects of a splenectomy and splenic artery ligation on liver
regeneration at 30 days after the operation (POD) using the Ki-67
labelling index (LI). The Ki-67 LI (proportion of hepatocytes with
nuclei positively stained for Ki-67) was expressed as a percentage
for all hepatocytes (morphologically determined) in randomly chosen
sections (Ten fields selected at random from each of 3 rats; total of
30 fields were examined in each group.). Values are mean  SD.
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functional splenic tissue after splenic artery ligation in the
methyl-cellulose-induced hypersplenism rat model27 and recovery
of splenic blood flow even after ligation of the splenic hilar artery
because of the collateral venous circulation.28 Considered
together, the above studies and the results of the present experi-
ments imply that splenic artery ligation does not completely
abolish splenic viability, which may allow continued production
of TGF-b1 in the spleen and its resultant release into the portal
vein.
The fibrotic rate in the SP group was significantly lower than in
the SAL group. While the SAL group improved liver fibrosis in
comparison with the sham operation rats, the extent of improve-
ment was not equal to that observed after a splenectomy, probably
because the plasma TGF-b1 level in the SAL group was not sig-
nificantly lower than that of the CT group. This result suggests
that splenic artery ligation with preservation of some splenic
tissue did not relate to the reduction of fibrosis. In hepatic inflam-
mation, the severity of the inflammatory process correlates with
the extent fibrogenesis.29 Our findings may explain the signifi-
cantly small area of fibrosis in the liver of rats of the SAL group
that showed no reduction in plasma concentrations of TGF-b1
compared with the CT group.
Both ALT and T. Bil significantly improved in the splenecto-
mized animals. Reduced fibrosis in the Disse’s space improves ALT
and T. Bil,14,22 as severe fibrosis in the Disse’s space may block the
exchange of molecules between the sinusoidal spaces and hepato-
cytes.19 In our study, splenic artery ligation tended to improve liver
function, similar to a splenectomy. Splenic artery ligation also
reduced the severity of histopathological liver damage, such as
degenerative hepatocytes, moderate inflammatory cell infiltration
and hepatic necrosis. It also decreased the fibrotic rate of the live
compared with the CT group. Our findings suggest that the reduc-
tion in the extent of liver damage and liver fibrosis was probably
the underlying mechanism of splenic artery ligation-induced
improvement of liver function. The present study also showed
that compared with splenic artery ligation, a splenectomy resulted
in better improvement of liver damage, marked reduction of
inflammatory cell infiltration and extent of fibrosis. These positive
effects of a splenectomy may be related to the improvement of
liver function. It is noteworthy that other spleen-derived factors
also impair liver regeneration in cirrhotic liver, such as HGF
activator-inhibitor (HAI)30 and endotheline-1 (ET-1).31 Further
experimental and clinical studies are needed to elucidate the
importance of TGF-b1 expression.
In the present study, a splenectomy resulted in significant
improvement of liver regeneration and lessening of liver fibrosis
compared with splenic artery ligation. The most important dif-
ference between splenic artery ligation and a splenectomy is con-
sidered to be the reduction in the TGF-b1 level, which inhibits
hepatocyte regeneration and promotes fibrosis. Our results high-
light the benefits of a splenectomy in improvement of liver regen-
eration in patients with cirrhosis. Prospective clinical studies are
required to validate these findings.
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